Objective: The mortality of conventional coronary artery bypass grafting after acute myocardial infarction remains high. This study compared the clinical outcomes of patients undergoing conventional and on-pump beating-heart coronary artery bypass grafting and evaluated the efficacy of an on-pump beating-heart technique for the surgical treatment of these critically ill patients.
Results: A significant reduction occurred in the observed mortality between the conventional and on-pump beating groups (21.7% vs 2.6%, P 5 .04), despite a higher predicted mortality risk calculated by using EuroSCORE (9.0 6 1.6 vs 9.6 6 1.6, P 5 .048) and a greater use of a preoperative intra-aortic balloon pump (43.5% vs 78.9%, P 5 .005). On-pump beating-heart patients received fewer bypass grafts than conventional patients (2.0 vs 2.9, P 5 .001), but the internal thoracic artery was used more often in on-pump beating-heart patients (P 5 .014). Three patients in the conventional coronary artery bypass grafting group required new insertion of an intra-aortic balloon pump, whereas no patients required this in the on-pump beating-heart group (P 5 .220). Postoperative renal failure requiring hemodialysis occurred in 2 patients in the conventional coronary artery bypass grafting group but in no patients in the on-pump beating-heart group (P 5 .138).
Conclusions: On-pump beating-heart coronary artery bypass grafting is the preferred method of emergency myocardial revascularization for patients with acute myocardial infarction who might tolerate cardioplegic arrest poorly. It has lower postoperative mortality and morbidity than conventional coronary artery bypass grafting. F ibrinolytic therapy, percutaneous coronary intervention (PCI), or both is the preferred first-line therapy for acute myocardial infarction (AMI). 1 Coronary artery bypass grafting (CABG) in the presence of or immediately after AMI is controversial because the mortality from emergency CABG for AMI remains high.
2-5 However, we sometimes encounter selected patients requiring emergency surgical revascularization. Despite recent improvements in myocardial preservation techniques and the use of cardiac-assist devices, such as an intra-aortic balloon pump (IABP), the technique of aortic crossclamping and cardioplegic arrest (conventional CABG) might induce myocardial and systemic organ damage during this critical situation.
To reduce the damaging effect of cardiac arrest and the mortality rate, we adopted the technique of on-pump beating-heart CABG. In this study we compared the clinical outcomes and laboratory data of patients undergoing conventional and on-pump beating-heart CABG and evaluated the efficacy of the on-pump beating-heart technique for the surgical treatment of AMI. The diagnosis of AMI was based on clinical criteria, including electrocardiographic evidence (Q waves and ST-segment elevation) and characteristic increase in serum myocardial enzyme levels (creatine phosphokinase). All patients underwent emergency coronary angiography performed preoperatively by a cardiologist. Indications for emergency CABG included the following: patients with a contraindication for thrombolytic therapy, patients with coronary lesions unsuitable for primary PCI (including left main, complicated, and multiple lesions), and cardiogenic shock defined as a systolic blood pressure of less than 80 mm Hg with or without IABP and pressor support, as well as clinical signs of hypoperfusion. The criteria for preoperative insertion of an IABP were as follows: cardiogenic shock or refractory ventricular failure, hemodynamic instability with or without catecholamines, unstable refractory angina, intractable ventricular arrhythmia, and a critical left main stenosis ($70%). Excluded from the analysis were patients who underwent surgical intervention for the mechanical complications of AMI (ventricular septum rupture, ruptured papillary muscle, or ventricular rupture), as well as patients who required additional procedures, such as left ventricular aneurysm or valve repair.
Surgical Techniques
Conventional CABG. A standardized anesthetic protocol was used in all patients. All operations were performed through a median sternotomy. Conduits were harvested and prepared, and the patients were heparinized with an initial dose of 300 IU/kg heparin to achieve a target activated clotting time of greater than 450 seconds. Cardiopulmonary bypass (CPB) was established by means of aortic cannulation and bicaval venous drainage. The left ventricle was consistently vented through the right superior pulmonary vein.
The standard CPB circuit incorporated a roller pump and a hollow-fiber membrane oxygenator. The extracorporeal circuit was primed with 1000 mL of Hartmann solution, 150 mL of mannitol, 20 mL of sodium bicarbonate, and 4000 IU of heparin. The nonpulsatile flow was adjusted to between 2.0 and 2.5 L $ min 21 $ m 22 , and the blood pressure was maintained between 50 and 70 mm Hg. The systemic temperature was kept between 34 C and 36 C.
The aorta was crossclamped, and myocardial protection was achieved with intermittent antegrade and retrograde tepid blood cardioplegia. The cardioplegic solution and delivery were the same as described by Caputo and colleagues. 6 After the induction of ischemic arrest with dose 1 (300 mL/min blood for 2 minutes, 20 mEq/ L [K], and 5 mEq/L [Mg]), subsequent doses were administered every 20 minutes. The distal anastomoses were constructed first with running sutures of 7-0 polypropylene, and the proximal anastomoses were connected to the ascending aorta with 6-0 polypropylene sutures during a single crossclamp period. After the patient was weaned from CPB and decannulated, the heparin was reversed.
On-pump beating-heart CABG. The anesthetic protocol, heparin dose, and CPB circuit were the same as with conventional CABG. CPB was established by means of aortic cannulation and insertion of a 2-stage venous cannula through the right atrial appendage. The operation was then continued on the assisted beating heart. The distal anastomoses were constructed before the proximal anastomoses. The left anterior descending coronary artery was revascularized first, followed by the circumflex and right coronary arteries. Regional myocardial immobilization was achieved with a suction stabilizer (Octopus, Medtronic, Minneapolis, Minn; Guidant Acrobat, Guidant, Indianapolis, Ind). An apical suction cardiac positioning device (Starfish, Medtronic) was used in revascularization of the circumflex and right coronary arteries to facilitate exposure. During construction of the anastomoses, target vessel hemostasis was obtained with intravascular shunts (Clearview, Medtronic) or temporary occlusion of the proximal coronary artery. All distal anastomoses were made with running sutures of 7-0 polypropylene. The proximal anastomoses were created with 6-0 polypropylene sutures under a partial occlusion clamp or proximal anastomotic system (Heartstring, Guidant). A humidified carbon dioxide blower was used for better visualization. After weaning from CPB and decannulation, the heparin was reversed.
Statistical Analysis
The results for categorical variables are expressed as numbers (percentages). Continuous variables are presented as the mean 6 standard deviation. The Fisher exact test or the c 2 test was used to compare categorical variables. The continuous variables were compared by using the Student t test.
Results
The respective number of patients with AMI hospitalized, the number of patients with AMI with PCI, the number of CABG procedures, and the number of cases thrombolytic or medical therapy used during the same period were 422, 371, 23, and 28 in the conventional CABG group and 415, 353, 38, and 24 in the on-pump beating-heart CABG group. In both groups surgical patients constituted 5.5% versus 8.4% of all patients with AMI hospitalized during the same time period, respectively (P 5 .06).
The demographic and preoperative patient characteristics of the 2 groups are presented in Table 1 . No significant differences were observed between the groups in terms of age, sex, comorbidities, number of diseased vessels, AMI location, left main trunk lesion, shock, creatinine, and creatinine kinase myocardial band (CK-MB) values. All patients in the conventional group and 36 (94.7%) of 38 patients in the onpump beating-heart group had multivessel disease. Therefore only 2 patients had single-vessel disease: one was in cardiogenic shock, and the other had a long left anterior descending coronary artery lesion that was not suitable for PCI.
The predicted mortality risk calculated by using Euro-SCORE 7 was significantly higher in the on-pump beatingheart CABG group than in the conventional CABG group (9.9 6 1.6 vs 9.0 6 1.6, P 5 .048). The preoperative use of IABP was also greater in the on-pump beating-heart CABG group (78.9% vs 43.5%, P 5 .005). These data mean that patients undergoing on-pump beating-heart CABG were in more critical states than the patients undergoing conventional CABG.
The time interval from the onset of AMI to CABG was similar (27.0 6 22.0 vs 18.3 6 17.1 hours, P 5 .100). Table 2 lists the breakdown of the specific timing of CABG after AMI and mortality. No significant difference was observed between the groups.
All patients in both groups had ST-segment elevation. Nineteen of 23 patients in the conventional CABG group and 29 of 38 patients in the on-pump beating-heart CABG group had a Q wave (82.6% vs 76.3%, P 5 .404). Table 3 shows the intraoperative variables of the patients. The CPB time was significantly longer in the conventional CABG group than in the on-pump beating-heart CABG group (185 6 49 vs 126 6 36 minutes, P 5 .0001). The on-pump beating-heart CABG group underwent fewer bypass grafts per patient (2.0 6 0.7 vs 2.9 6 0.9, P 5 .001). We tried to bypass not only the vessel responsible for AMI but also the target vessels that could be bypassed. Left anterior descending coronary artery bypass was performed, except in one case in the on-pump beating-heart group. The internal thoracic artery was used more often in patients undergoing on-pump beating-heart CABG (39.1% vs 71.1%, P 5 .014). Three patients in the conventional CABG group required new insertion of an IABP, whereas no patients required this in the on-pump beating-heart CABG group, although the difference was not statistically significant (P 5 .220).
The postoperative patient findings and early outcome data are presented in Table 4 . The postoperative maximum CK-MB values in the conventional CABG group were higher than those in the on-pump beating-heart CABG group (188 6 359 vs 106 6 86 IU/L), but the difference was not statistically significant. The duration of inotropic support, duration of IABP use, time to extubation, duration of intensive care unit stay, and length of hospital stay were lower in the onpump beating-heart CABG group, but these differences did not reach significance. All surviving patients underwent early postoperative coronary angiography during their hospital stays. Graft patency in the on-pump beating-heart CABG group was similar to that of the conventional CABG group (98.5% vs 95.7%). Postoperative renal failure occurred in 2 patients in the conventional CABG group but in no patients in the on-pump beating-heart group (P 5 .138). These 2 patients required postoperative hemodialysis. No neurophysiologic complications developed in either group. Five hospital deaths occurred in the conventional CABG group (21.7%), whereas only 1 (2.6%) patient died in the on-pump CABG group. The hospital mortality rate was remarkably lower in the on-pump beating-heart CABG group (P 5 .04). Of the 3 patients with preoperative cardiogenic shock in each group, 2 patients died in the conventional group, whereas 1 patient died in the on-pump beating-heart group. The cause of death in all patients was low-output syndrome.
Discussion
With improved myocardial protection, anesthesia, and surgical techniques, CABG is generally safe and efficient, although high mortality and morbidity are still documented in emergency conventional CABG after AMI. [2] [3] [4] [5] The reasons for this poor result include both the patients' poor preoperative status, including cardiogenic shock 5 or organ failure, and myocardial damage after cardioplegic arrest.
As an alternative to conventional CABG for patients with AMI, we recently adopted on-pump beating-heart CABG. On-pump beating-heart CABG is an attractive technique that keeps a heartbeat with the aid of CPB but without aortic crossclamping or cardioplegic arrest. Izumi and associates 8 demonstrated that on-pump beating-heart CABG reduces the mortality of patients with AMI and decreases the release of CK-MB compared with conventional CABG. The avoidance of cardioplegic arrest can eliminate intraoperative global myocardial ischemia, which might contribute to myocardial protection. 9 The beating heart can preserve native coronary blood flow, which might reduce myocardial injury. 10 Historically, Sweeney and Frazier 11 demonstrated on-pump beating-heart bypass as an interesting tradeoff, using biventricular assist devices and the b-blocker esmolol during coronary revascularization in severely ill patients. Perrault and colleagues 9 described on-pump beating-heart coronary operations as an acceptable tradeoff between conventional CABG and off-pump coronary artery bypass in high-risk patients. Experimentally, it has been demonstrated that maintaining the heartbeat results in minimal myocardial edema and better left ventricular function. 12 Another advantage of on-pump beating-heart surgery is that it allows optimal exposure of the coronary arteries. 13 This avoids extreme upward retraction of the heart, especially during revascularization of the circumflex branch, 14 which might contribute to better myocardial protection. 14 Theoretically, off-pump CABG seems to be an ideal procedure. Several studies, [15] [16] [17] [18] [19] [20] including randomized controlled studies 18, 19 and a propensity score analysis, 20 have compared off-pump and conventional CABG and revealed that off-pump CABG in selected patients is safe and has a short-term cardiac outcome comparable with that of conventional CABG. However, most of these studies excluded emergency patients with AMI, left main coronary artery stenosis, reoperation, or major left ventricular hypertrophy or dilatation. Few reports are available on the outcome of offpump CABG for AMI. Locker and coworkers 21 demonstrated that emergency off-pump CABG for AMI results in lower mortality compared with conventional CABG (5% vs 24%); however, the late mortality increased, and the longterm results of patients operated on without CPB were no better than the results of those operated on with CPB, which might have been related to the incomplete revascularization or inferior patency rate of anastomoses performed on the beating heart. Others have also reported an inferior graft patency rate or recurrent symptoms compared with the conventional technique. 16, 19 Note that off-pump CABG is essentially associated with an acute conversion risk, which causes death and serious complications in the hospital. [22] [23] [24] [25] [26] [27] In 2004, 4.5% of patients in Japan were converted from off-pump coronary artery bypass to on-pump bypass in isolated, primary, emergency CABG, and their hospital mortality reached 23.8%. 22 The conversion risks are difficult to quantify precisely. 25 Suggested predictors of conversion have included previous CABG, congestive heart failure, a surgeon with insufficient experience, a low ejection fraction, and recent myocardial infarction. 23, 26, 28 We do not believe that off-pump CABG should be used in all patients with AMI. An appropriate circulatory support system should be applied to improve their hemodynamic 13 Vassiliades and associates 26 suggested considering the on-pump beating-heart technique to prevent catastrophic sudden hemodynamic collapse in CABG. CPB can unload the heart and guarantee adequate organ perfusion. 10 In our experience we found no difference in the incidence of renal failure, although on-pump beating-heart CABG seems to cause significantly less renal dysfunction. 13 The drawback of the on-pump beating-heart CABG technique is the cost increase caused by both perfusion costs and the cost of disposable devices. Another disadvantage is that it requires manipulation of the ascending aorta for inflow cannula insertion, which might cause atheromatous macroemboli. 29 We must consider femoral cannulation when possible atheromatous changes of the ascending aorta exist.
A worrisome finding in our study was the less-complete revascularization in our on-pump beating-heart patients. The reason for this difference might be that the number of the grafts was due to the surgeon's preference at the time of surgical intervention. Although incomplete revascularization did not increase the early risk, it might affect the longterm results of revascularization. 16, 21 Therefore the patients require careful follow-up as outpatients.
Limitations
Our study has several limitations. First, this study was a clinical review of patients who underwent conventional and onpump beating-heart primary CABG. Patients were not assigned to either group randomly, and a historical difference existed between the 2 groups. Second, the number of patients in each group was small. Further studies are necessary and expected.
Conclusions
Our experience suggests that on-pump beating-heart CABG is the preferable method of emergency myocardial revascularization for patients with AMI who might tolerate cardioplegic arrest poorly. It has a lower mortality and morbidity than conventional CABG.
